Biocompatible polymer protection for vaccines and drugs

A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called anaphylaxis. Researchers at the National Institute of Advanced Industrial Science and Technology ...

Successful completion of Lassa fever vaccine trial

The Vaccine Group, a University of Plymouth spinout company, has successfully completed a project to develop a transmissible vaccine for use in the rats that spread Lassa fever and to reduce its threat to humans.

Researchers develop a safer carrier for cancer vaccines

Lipid nanoparticle (LNP)-based messenger ribonucleic acid (mRNA) vaccines have recently emerged as a promising strategy for the prevention and treatment of cancers, as well as infectious diseases. LNPs are carriers that safely ...

Tablet-based vaccine prevents urinary tract infections in mice

Biomedical engineers at Duke University have developed a tablet-based vaccine for urinary tract infections (UTIs) that rapidly dissolves when placed under the tongue. The new treatment could offer an easy and practical alternative ...

page 10 from 39